Chelation therapy is the removal of heavy metals from the body
by using an agent to attract an ion of metal, inactivate it,
and then remove it from the body. Its primary applications are
to treat cardiovascular disease and heavy metal toxicity. There
is a growing body of empirical evidence that EDTA chelation therapy
is effective in treating cardiovascular diseases such as hypertension,
atherosclerosis, pre-stroke thrombosis, coronary artery disease,
angina, and peripheral vascular insufficiency. The National Institute
of Health is currently conducting a large scale study to investigate
this use of EDTA chelation.
Another use of chelation therapy is for conditions relating
to heavy metal toxicity. Tremors, Alzheimer’s, ALS, autism,
cognitive dysfunction, speech and learning disorders, and immune
dysfunction are just some of the conditions that can be caused
by chronic heavy metal toxicity. At WIN Clinic we perform testing
for heavy metal toxicity and provide effective treatment for
correcting a chronic heavy metal burden.
Chelation therapy is most often given into a vein (intravenously),
either as a short injection or over a period of 2 to 4 hours.
A typical treatment cycle may include 20 injections or infusions
spread over 10 to 12 weeks. Chelation therapy can also be given
orally. Typically, chelation therapy is done in several cycles
in order to get the most benefit.
There are various chelating agents for different types of toxicity.
The most commonly used are:
EDTA is an effective intravenous chelator for iron, lead, mercury,
cadmium, zinc, and calcium.
Alpha lipoic acid is especially useful as an oral chelator for
mercury, arsenic, and antimony.
DMPS is a good oral chelator of mercury, lead, silver, cadmium,
nickel, arsenic, antimony, copper, molybdenum, zinc, and manganese.
DMPS can also be administered intravenously.
DMSA is used orally for chelating lead, cadmium, mercury, silver,
nickel, arsenic, molybdenum, copper, zinc, manganese, and iron.